Reversible cross-tolerance to platelet-activating factor signaling by bacterial toxins

References

• Lakshmikanth CL, Jacob SP, Chaithra VH, de Castro-faria-neto HC, Marathe GK. Sepsis: in search of cure. Inflamm Res 2016;65:587–602.
   PubMed Web of Science ®Google Scholar
• Lakshmikanth CL, Jacob SP, Kudva AK, Latchoumycandane C, Yashaswini PSM, Sumanth MS, Goncalves-de-Albuquerque CF, Silva AR, Singh SA, Castro-Faria-Neto HC. Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia–like pathology in Swiss albino mice. Sci Rep 2016;6:34666.
   PubMed Web of Science ®Google Scholar
• Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005;12:60–67.
   PubMedGoogle Scholar
• Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, Theilacker C, Hübner J, Santos-Sierra S, Teti G, Golenbock DT. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 2008;180:6149–6158.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135–145.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1–14.
   PubMed Web of Science ®Google Scholar
• Maeshima N, Fernandez R. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol 2013;3:3.
   PubMed Web of Science ®Google Scholar
• Schröder NW, Morath S, Alexander C, Hamann L, Hartung T, Zähringer U, Göbel UB, Weber JR, Schumann RR. Lipoteichoic acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003;278:15587–15594.
   PubMed Web of Science ®Google Scholar
• Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000;165:618–622.
   PubMed Web of Science ®Google Scholar
• Sumanth MS, Abhilasha KV, Jacob SP, Chaithra VH, Basrur V, Willard B, McIntyre TM, Prabhu KS, Marathe GK. Acute phase protein, α–1-acid glycoprotein (AGP-1), has differential effects on TLR-2 and TLR-4 mediated responses. Immunobiology 2019;224:672–680.
   PubMed Web of Science ®Google Scholar
• Neilsen PO, Zimmerman GA, McIntyre TM. Escherichia coli Braun lipoprotein induces a lipopolysaccharide-like endotoxic response from primary human endothelial cells. J Immunol 2001;167:5231–5239.
   PubMed Web of Science ®Google Scholar
• Sacre SM, Lundberg AM, Andreakos E, Taylor C, Feldmann M, Foxwell BM. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-κB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J Immunol 2007;178:2148–2154.
   PubMed Web of Science ®Google Scholar
• Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Barbacci EG, Hujer K, Bonomo RA. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. mBio 2012;3:e00312.
   PubMed Web of Science ®Google Scholar
• Watanabe J, Marathe GK, Neilsen PO, Weyrich AS, Harrison KA, Murphy RC, Zimmerman GA, McIntyre TM. Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles. J Biol Chem 2003;278:33161–33168.
   PubMed Web of Science ®Google Scholar
• Corl C, Gandy J, Sordillo L. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells. J Dairy Sci 2008;91:3067–3078.
   PubMed Web of Science ®Google Scholar
• Miotla JM, Jeffery PK, Hellewell PG. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 1998;18:197–204.
   PubMed Web of Science ®Google Scholar
• Ogata M, Nandate K, Kawasaki T, Kawasaki C, Ozaki M, Shigematsu A. A platelet activating factor receptor antagonist inhibits cytokine production in human whole blood by bacterial toxins and live bacteria. Anesth Analg 2004;98:1767–1772.
   PubMed Web of Science ®Google Scholar
• Çöl R, Keskin E. Effects of platelet-activating factor receptor antagonist (PAFRA) on selected inflammatory and biochemical parameters in lipopolysaccharide-induced rat endotoxemia model. Kafkas Univ Vet Fak Derg 2013;19:97–102.
   Web of Science ®Google Scholar
• Marathe GK, McIntyre TM. PAF is a potent pyrogen and cryogen in rodents, but it does not mediate thermoregulatory responses to bacterial endotoxin. Temperature 2015;2:449–450.
   PubMedGoogle Scholar
• Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao W-H, Kume K, Fukuchi Y, Ikuta K. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 1998;187:1779–1788.
   PubMed Web of Science ®Google Scholar
• Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000;69:419–445.
   PubMed Web of Science ®Google Scholar
• Gomes RN, Bozza FA, Amâncio RT, Japiassú AM, Vianna RC, Larangeira AP, Gouvêa JM, Bastos MS, Zimmerman GA, Stafforini DM. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 2006;26:41–49.
   PubMed Web of Science ®Google Scholar
• Demopoulos C, Pinckard R, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979;254:9355–9358.
   PubMed Web of Science ®Google Scholar
• Ishii S, Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 2000;39:41–82.
   PubMed Web of Science ®Google Scholar
• Marathe GK, Pandit C, Lakshmikanth CL, Chaithra VH, Jacob SP, D’Souza CJM. To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase. J Lipid Res 2014;55:1847–1854.
   PubMed Web of Science ®Google Scholar
• Marques SA, Dy LC, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB, Spandau DF. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther 2002;300:1026–1035.
   PubMed Web of Science ®Google Scholar
• Honda Z-I, Ishii S, Shimizu T. Platelet-activating factor receptor. J Biochem 2002;131:773–779.
   PubMed Web of Science ®Google Scholar
• Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 2003;40:643–672.
   PubMed Web of Science ®Google Scholar
• Abhilasha KV, Sumanth MS, Chaithra VH, Jacob SP, Thyagarajan A, Sahu RP, Rajaiah R, Prabhu KS, Kemparaju K, Travers JB. p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice. Free Radic Biol Med 2019;143:275–287.
   PubMed Web of Science ®Google Scholar
• Ishii S, Nagase T, Shimizu T. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 2002;68:599–609.
   PubMed Web of Science ®Google Scholar
• Jacob SP, Lakshmikanth CL, Chaithra VH, Kumari TRS, Chen C-H, McIntyre TM, Marathe GK. Lipopolysaccharide cross-tolerance delays platelet-activating factor-induced sudden death in Swiss albino mice: involvement of cyclooxygenase in cross-tolerance. PLoS One 2016;11:e0153282.
   PubMed Web of Science ®Google Scholar
• Chaithra VH, Jacob SP, Lakshmikanth CL, Sumanth MS, Abhilasha KV, Chen C-H, Thyagarajan A, Sahu RP, Travers JB, McIntyre TM. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF. J Lipid Res 2018;59:2063–2074.
   PubMed Web of Science ®Google Scholar
• Travers JB, Murphy RC, Johnson CA, Pei Y, Morin SM, Clay KL, Barber LA, Hood AF, Morelli JG, Williams DA. Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. Prostaglandins Other Lipid Mediat 1998;56:305–324.
   PubMed Web of Science ®Google Scholar
• Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC, Fertel RH, Nguyen TM, Williams DA, Travers JB. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 1998;161:1954–1961.
   PubMed Web of Science ®Google Scholar
• Sahu RP, Petrache I, Van Demark MJ, Rashid BM, Ocana JA, Tang Y, Yi Q, Turner MJ, Konger RL, Travers JB. Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J Immunol 2013;190:2447–2454.
   PubMed Web of Science ®Google Scholar
• Lakshmikanth CL, Jacob SP, Divya A, Rao ARGA, Gopal MK. Interference of phenol during quantification of a bacterial lipoprotein. Biokemistri 2015;27:123–128.
   Google Scholar
• Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005;123:172–183.
   PubMed Web of Science ®Google Scholar
• Lee -J-J, Kim T, Cho W-K, Ma JY. Antithrombotic and antiplatelet activities of Soshiho-tang extract. BMC Complement Altern Med 2013;13:137.
   PubMed Web of Science ®Google Scholar
• Terashita Z-I, Imura Y, Nishikawa K. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Biochem Pharmacol 1985;34:1491–1495.
   PubMed Web of Science ®Google Scholar
• Fukunaga K, Ishii S, Asano K, Yokomizo T, Shiomi T, Shimizu T, Yamaguchi K. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. J Biol Chem 2001;276:43025–43030.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Honda Z-I, Waga I, Matsumoto T, Noma M, Shimizu T. Endotoxin transduces Ca2+ signaling via platelet-activating factor receptor. FEBS Lett 1992;314:125–129.
   PubMed Web of Science ®Google Scholar
• Ju D, Zheng Q, Wang H, Wang X, Fang J. Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages. Acta Pharm Sin 1993;28:721–727.
   Google Scholar
• Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, Kume K, Miyazaki J, Shimizu T. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor. EMBO J 1997;16:133–142.
   Google Scholar
• Jeong Y-I, Jung ID, Lee C-M, Chang JH, Chun SH, Noh KT, Kyung Jeong S, Shin YK, Lee WS, Kang MS. The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock. PLoS One 2009;4:e6503.
   PubMed Web of Science ®Google Scholar
• Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002;419:77–81.
   PubMed Web of Science ®Google Scholar
• Rajaiah R, Perkins DJ, Polumuri SK, Zhao A, Keegan AD, Vogel SN. Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages. J Immunol 2013;190:4763–4772.
   PubMed Web of Science ®Google Scholar
• Park SH, Park-Min K-H, Chen J, Hu X, Ivashkiv LB. TNF induces endotoxin tolerance mediated by GSK3 in macrophages. Nat Immunol 2011;12:607.
   PubMed Web of Science ®Google Scholar
• Aslam R, Speck ER, Kim M, Crow AR, Bang KA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo. Blood 2006;107:637–641.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11:264–274.
   PubMed Web of Science ®Google Scholar
• Kapur R, Zufferey A, Boilard E, Semple JW. Nouvelle cuisine: platelets served with inflammation. J Immunol 2015;194:5579–5587.
   PubMed Web of Science ®Google Scholar
• Lemjabbar H, Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 2002;8:41–46.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest 2005;115:2855–2861.
   PubMed Web of Science ®Google Scholar
• Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001;166:5161–5167.
   PubMed Web of Science ®Google Scholar
• Saturnino SF, Prado RO, Cunha-Melo JR, Andrade MV. Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcεR1 interactions and SOCS expression: perspectives on immunomodulation in infectious and allergic diseases. BMC Infect Dis 2010;10:240.
   PubMed Web of Science ®Google Scholar
• Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FER, Simons KJ, Cass D, Yeung J. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358:28–35.
   PubMed Web of Science ®Google Scholar